These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia. Woldeyohannes D, Assefa T, Aman R, Tekalegn Y, Hailemariam Z. PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154 [Abstract] [Full Text] [Related]
3. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia. Shibabaw A, Gelaw B, Wang SH, Tessema B. PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658 [Abstract] [Full Text] [Related]
4. National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study. Tola H, Holakouie-Naieni K, Mansournia MA, Yaseri M, Gamtesa DF, Tesfaye E, Mahamed Z, Sisay MM. BMJ Open; 2021 Aug 10; 11(8):e040862. PubMed ID: 34376436 [Abstract] [Full Text] [Related]
7. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study. Meressa D, Hurtado RM, Andrews JR, Diro E, Abato K, Daniel T, Prasad P, Prasad R, Fekade B, Tedla Y, Yusuf H, Tadesse M, Tefera D, Ashenafi A, Desta G, Aderaye G, Olson K, Thim S, Goldfeld AE. Thorax; 2015 Dec 10; 70(12):1181-8. PubMed ID: 26506854 [Abstract] [Full Text] [Related]
9. Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients' data analysis for outcome and effectiveness of the current regimens. Eshetie S, Alebel A, Wagnew F, Geremew D, Fasil A, Sack U. BMC Infect Dis; 2018 Sep 27; 18(1):486. PubMed ID: 30261852 [Abstract] [Full Text] [Related]
10. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study. Bade AB, Mega TA. PLoS One; 2020 Sep 27; 15(11):e0241684. PubMed ID: 33166299 [Abstract] [Full Text] [Related]
11. Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study. Woldeyohannes D, Tekalegn Y, Sahiledengle B, Assefa T, Aman R, Hailemariam Z, Mwanri L, Girma A. PLoS One; 2021 Sep 27; 16(5):e0250804. PubMed ID: 33956812 [Abstract] [Full Text] [Related]
12. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study. Javaid A, Ullah I, Masud H, Basit A, Ahmad W, Butt ZA, Qasim M. Clin Microbiol Infect; 2018 Jun 27; 24(6):612-617. PubMed ID: 28970158 [Abstract] [Full Text] [Related]
13. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach. Gezae KE, Abebe HT, Gebretsadik LG. BMC Infect Dis; 2019 Feb 04; 19(1):107. PubMed ID: 30717705 [Abstract] [Full Text] [Related]
17. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. Atif M, Bashir A, Ahmad N, Fatima RK, Saba S, Scahill S. BMC Infect Dis; 2017 Sep 29; 17(1):655. PubMed ID: 28962599 [Abstract] [Full Text] [Related]